REPORT ID 7140

Global Non-Tyrosine Kinase Inhibitors Market Research Report 2017

Publish Date
2-Nov-17
Pages
113
Format
Electronic (PDF)

In this report, the global Non-Tyrosine Kinase Inhibitors market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Non-Tyrosine Kinase Inhibitors in these regions, from 2012 to 2022 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global Non-Tyrosine Kinase Inhibitors market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    Roche
    Eli Lilly
    Novartis
    Array BioPharma
    Nerviano Medical Sciences
    Pfizer
    Merck KGaA
    Astex Pharmaceuticals
    Cyclacel Pharmaceuticals
    Daiichi Sankyo
    Onconova Therapeutics
    AstraZeneca
    GlaxoSmithKline (GSK)
    Carna Biosciences
    Celgene Corporation
    Eternity Bioscience
    Jasco Pharmaceuticals
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    mTOR Inhibitors
    RAF/MEK Inhibitors
    CDK Inhibitors
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    Liver Cancer
    Respiratory Cancer
    Brain Cancer
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Non-Tyrosine Kinase Inhibitors Market Research Report 2017
1 Non-Tyrosine Kinase Inhibitors Market Overview
    1.1 Product Overview and Scope of Non-Tyrosine Kinase Inhibitors
    1.2 Non-Tyrosine Kinase Inhibitors Segment by Type (Product Category)
        1.2.1 Global Non-Tyrosine Kinase Inhibitors Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
        1.2.2 Global Non-Tyrosine Kinase Inhibitors Production Market Share by Type (Product Category) in 2016
        1.2.3 mTOR Inhibitors
        1.2.4 RAF/MEK Inhibitors
        1.2.5 CDK Inhibitors
    1.3 Global Non-Tyrosine Kinase Inhibitors Segment by Application
        1.3.1 Non-Tyrosine Kinase Inhibitors Consumption (Sales) Comparison by Application (2012-2022)
        1.3.2 Liver Cancer
        1.3.3 Respiratory Cancer
        1.3.4 Brain Cancer
        1.3.5 Others
    1.4 Global Non-Tyrosine Kinase Inhibitors Market by Region (2012-2022)
        1.4.1 Global Non-Tyrosine Kinase Inhibitors Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
        1.4.2 North America Status and Prospect (2012-2022)
        1.4.3 Europe Status and Prospect (2012-2022)
        1.4.4 China Status and Prospect (2012-2022)
        1.4.5 Japan Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Status and Prospect (2012-2022)
        1.4.7 India Status and Prospect (2012-2022)
    1.5 Global Market Size (Value) of Non-Tyrosine Kinase Inhibitors (2012-2022)
        1.5.1 Global Non-Tyrosine Kinase Inhibitors Revenue Status and Outlook (2012-2022)
        1.5.2 Global Non-Tyrosine Kinase Inhibitors Capacity, Production Status and Outlook (2012-2022)

2 Global Non-Tyrosine Kinase Inhibitors Market Competition by Manufacturers
    2.1 Global Non-Tyrosine Kinase Inhibitors Capacity, Production and Share by Manufacturers (2012-2017)
        2.1.1 Global Non-Tyrosine Kinase Inhibitors Capacity and Share by Manufacturers (2012-2017)
        2.1.2 Global Non-Tyrosine Kinase Inhibitors Production and Share by Manufacturers (2012-2017)
    2.2 Global Non-Tyrosine Kinase Inhibitors Revenue and Share by Manufacturers (2012-2017)
    2.3 Global Non-Tyrosine Kinase Inhibitors Average Price by Manufacturers (2012-2017)
    2.4 Manufacturers Non-Tyrosine Kinase Inhibitors Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Non-Tyrosine Kinase Inhibitors Market Competitive Situation and Trends
        2.5.1 Non-Tyrosine Kinase Inhibitors Market Concentration Rate
        2.5.2 Non-Tyrosine Kinase Inhibitors Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Non-Tyrosine Kinase Inhibitors Capacity, Production, Revenue (Value) by Region (2012-2017)
    3.1 Global Non-Tyrosine Kinase Inhibitors Capacity and Market Share by Region (2012-2017)
    3.2 Global Non-Tyrosine Kinase Inhibitors Production and Market Share by Region (2012-2017)
    3.3 Global Non-Tyrosine Kinase Inhibitors Revenue (Value) and Market Share by Region (2012-2017)
    3.4 Global Non-Tyrosine Kinase Inhibitors Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.5 North America Non-Tyrosine Kinase Inhibitors Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.6 Europe Non-Tyrosine Kinase Inhibitors Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.7 China Non-Tyrosine Kinase Inhibitors Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.8 Japan Non-Tyrosine Kinase Inhibitors Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.9 Southeast Asia Non-Tyrosine Kinase Inhibitors Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.10 India Non-Tyrosine Kinase Inhibitors Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Non-Tyrosine Kinase Inhibitors Supply (Production), Consumption, Export, Import by Region (2012-2017)
    4.1 Global Non-Tyrosine Kinase Inhibitors Consumption by Region (2012-2017)
    4.2 North America Non-Tyrosine Kinase Inhibitors Production, Consumption, Export, Import (2012-2017)
    4.3 Europe Non-Tyrosine Kinase Inhibitors Production, Consumption, Export, Import (2012-2017)
    4.4 China Non-Tyrosine Kinase Inhibitors Production, Consumption, Export, Import (2012-2017)
    4.5 Japan Non-Tyrosine Kinase Inhibitors Production, Consumption, Export, Import (2012-2017)
    4.6 Southeast Asia Non-Tyrosine Kinase Inhibitors Production, Consumption, Export, Import (2012-2017)
    4.7 India Non-Tyrosine Kinase Inhibitors Production, Consumption, Export, Import (2012-2017)

5 Global Non-Tyrosine Kinase Inhibitors Production, Revenue (Value), Price Trend by Type
    5.1 Global Non-Tyrosine Kinase Inhibitors Production and Market Share by Type (2012-2017)
    5.2 Global Non-Tyrosine Kinase Inhibitors Revenue and Market Share by Type (2012-2017)
    5.3 Global Non-Tyrosine Kinase Inhibitors Price by Type (2012-2017)
    5.4 Global Non-Tyrosine Kinase Inhibitors Production Growth by Type (2012-2017)

6 Global Non-Tyrosine Kinase Inhibitors Market Analysis by Application
    6.1 Global Non-Tyrosine Kinase Inhibitors Consumption and Market Share by Application (2012-2017)
    6.2 Global Non-Tyrosine Kinase Inhibitors Consumption Growth Rate by Application (2012-2017)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Non-Tyrosine Kinase Inhibitors Manufacturers Profiles/Analysis
    7.1 Roche
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 Non-Tyrosine Kinase Inhibitors Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 Roche Non-Tyrosine Kinase Inhibitors Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.1.4 Main Business/Business Overview
    7.2 Eli Lilly
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 Non-Tyrosine Kinase Inhibitors Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 Eli Lilly Non-Tyrosine Kinase Inhibitors Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.2.4 Main Business/Business Overview
    7.3 Novartis
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 Non-Tyrosine Kinase Inhibitors Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 Novartis Non-Tyrosine Kinase Inhibitors Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.3.4 Main Business/Business Overview
    7.4 Array BioPharma
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 Non-Tyrosine Kinase Inhibitors Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 Array BioPharma Non-Tyrosine Kinase Inhibitors Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.4.4 Main Business/Business Overview
    7.5 Nerviano Medical Sciences
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 Non-Tyrosine Kinase Inhibitors Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 Nerviano Medical Sciences Non-Tyrosine Kinase Inhibitors Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.5.4 Main Business/Business Overview
    7.6 Pfizer
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 Non-Tyrosine Kinase Inhibitors Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 Pfizer Non-Tyrosine Kinase Inhibitors Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.6.4 Main Business/Business Overview
    7.7 Merck KGaA
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 Non-Tyrosine Kinase Inhibitors Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 Merck KGaA Non-Tyrosine Kinase Inhibitors Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.7.4 Main Business/Business Overview
    7.8 Astex Pharmaceuticals
        7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.8.2 Non-Tyrosine Kinase Inhibitors Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 Astex Pharmaceuticals Non-Tyrosine Kinase Inhibitors Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.8.4 Main Business/Business Overview
    7.9 Cyclacel Pharmaceuticals
        7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.9.2 Non-Tyrosine Kinase Inhibitors Product Category, Application and Specification
            7.9.2.1 Product A
            7.9.2.2 Product B
        7.9.3 Cyclacel Pharmaceuticals Non-Tyrosine Kinase Inhibitors Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.9.4 Main Business/Business Overview
    7.10 Daiichi Sankyo
        7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.10.2 Non-Tyrosine Kinase Inhibitors Product Category, Application and Specification
            7.10.2.1 Product A
            7.10.2.2 Product B
        7.10.3 Daiichi Sankyo Non-Tyrosine Kinase Inhibitors Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.10.4 Main Business/Business Overview
    7.11 Onconova Therapeutics
    7.12 AstraZeneca
    7.13 GlaxoSmithKline (GSK)
    7.14 Carna Biosciences
    7.15 Celgene Corporation
    7.16 Eternity Bioscience
    7.17 Jasco Pharmaceuticals

8 Non-Tyrosine Kinase Inhibitors Manufacturing Cost Analysis
    8.1 Non-Tyrosine Kinase Inhibitors Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Non-Tyrosine Kinase Inhibitors

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Non-Tyrosine Kinase Inhibitors Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Non-Tyrosine Kinase Inhibitors Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Non-Tyrosine Kinase Inhibitors Market Forecast (2017-2022)
    12.1 Global Non-Tyrosine Kinase Inhibitors Capacity, Production, Revenue Forecast (2017-2022)
        12.1.1 Global Non-Tyrosine Kinase Inhibitors Capacity, Production and Growth Rate Forecast (2017-2022)
        12.1.2 Global Non-Tyrosine Kinase Inhibitors Revenue and Growth Rate Forecast (2017-2022)
        12.1.3 Global Non-Tyrosine Kinase Inhibitors Price and Trend Forecast (2017-2022)
    12.2 Global Non-Tyrosine Kinase Inhibitors Production, Consumption , Import and Export Forecast by Region (2017-2022)
        12.2.1 North America Non-Tyrosine Kinase Inhibitors Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.2 Europe Non-Tyrosine Kinase Inhibitors Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.3 China Non-Tyrosine Kinase Inhibitors Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.4 Japan Non-Tyrosine Kinase Inhibitors Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.5 Southeast Asia Non-Tyrosine Kinase Inhibitors Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.6 India Non-Tyrosine Kinase Inhibitors Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
    12.3 Global Non-Tyrosine Kinase Inhibitors Production, Revenue and Price Forecast by Type (2017-2022)
    12.4 Global Non-Tyrosine Kinase Inhibitors Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach
        14.1.1 Research Programs/Design
        14.1.2 Market Size Estimation
        14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Disclaimer